Shawn Cross

Insider Reports History

Location
1825 K Street Suite 510, Washington, DC
Signature
/s/ Kristen Williams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shawn Cross:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pacira BioSciences, Inc. Chief Financial Officer Common Stock 56.3K $1.24M $22.09 Nov 10, 2025 Direct
Cyclo Therapeutics, Inc. Director Common Stock 136K $85.9K $0.63 Feb 27, 2025 Direct
Cyclo Therapeutics, Inc. Director Stock Option (Right to Buy) 15.6K Jun 3, 2024 Direct
Applied Molecular Transport Inc. CEO & Chair of the Board, Director Common Stock 0 $0.16 Dec 27, 2023 Direct
Applied Molecular Transport Inc. CEO & Chair of the Board, Director Stock Option (Right to Buy) 0 Dec 27, 2023 Direct

Insider Reports Filed by Shawn Cross

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCRX Pacira BioSciences, Inc. Nov 10, 2025 1 -$266K 4 Nov 13, 2025 Chief Financial Officer
PCRX Pacira BioSciences, Inc. Oct 31, 2025 1 -$143K 4 Nov 3, 2025 Chief Financial Officer
CYTH Cyclo Therapeutics, Inc. Feb 27, 2025 1 $0 4 Mar 3, 2025 Director
CYTH Cyclo Therapeutics, Inc. Nov 15, 2024 1 $0 4 Nov 18, 2024 Director
PCRX Pacira BioSciences, Inc. Nov 1, 2024 2 $0 4 Nov 5, 2024 Chief Financial Officer
PCRX Pacira BioSciences, Inc. Oct 21, 2024 0 $0 3 Oct 23, 2024 Chief Financial Officer
CYTH Cyclo Therapeutics, Inc. Aug 16, 2024 1 $0 4 Aug 20, 2024 Director
CYTH Cyclo Therapeutics, Inc. Jun 3, 2024 2 $0 4 Jun 5, 2024 Director
CYTH Cyclo Therapeutics, Inc. Dec 27, 2023 2 $0 4 Dec 28, 2023 Director
CYTH Cyclo Therapeutics, Inc. Dec 27, 2023 0 $0 3 Dec 28, 2023 Director
AMTI Applied Molecular Transport Inc. Dec 27, 2023 6 $0 4 Dec 28, 2023 CEO & Chair of the Board, Director
AMTI Applied Molecular Transport Inc. Nov 22, 2023 1 -$18.1K 4 Nov 24, 2023 CEO & Chair of the Board, Director
AMTI Applied Molecular Transport Inc. Nov 15, 2023 1 -$14.5K 4 Nov 16, 2023 CEO & Chair of the Board, Director
AMTI Applied Molecular Transport Inc. Sep 28, 2023 2 -$30.7K 4 Oct 2, 2023 CEO & Chair of the Board, Director
AMTI Applied Molecular Transport Inc. Jun 2, 2023 4 -$1.3K 4 Oct 4, 2023 CEO & Chair of the Board, Director
AMTI Applied Molecular Transport Inc. Mar 24, 2023 1 $0 4 Mar 27, 2023 CEO & Chair of the Board, Director
AMTI Applied Molecular Transport Inc. Mar 1, 2023 1 -$467 4 Mar 3, 2023 President & COO
AMTI Applied Molecular Transport Inc. Dec 2, 2022 1 -$4.09K 4 Dec 6, 2022 President & COO
AMTI Applied Molecular Transport Inc. Sep 1, 2022 2 -$1.26K 4 Sep 6, 2022 President & COO
AMTI Applied Molecular Transport Inc. Jun 1, 2022 2 -$11.8K 4 Jun 3, 2022 President & COO
AMTI Applied Molecular Transport Inc. May 16, 2022 2 $0 4 May 18, 2022 President & COO
AMTI Applied Molecular Transport Inc. Feb 15, 2022 2 $0 4 Feb 16, 2022 Chief Financial Officer
AMTI Applied Molecular Transport Inc. Dec 24, 2021 1 $0 4 Jan 6, 2022 Chief Financial Officer
BIOS BioPlus Acquisition Corp. Dec 2, 2021 0 $0 3 Dec 2, 2021 Director
AMTI Applied Molecular Transport Inc. Aug 19, 2021 6 -$255K 4 Aug 23, 2021 Chief Financial Officer